Colon cancer is diagnosed through a combination of colonoscopy and tissue biopsy, with colonoscopy being the primary tool that allows doctors to both visualize the inside of the colon and collect samples for lab analysis. No single blood test can confirm colon cancer. The path to diagnosis typically starts with either a routine screening test or an investigation of symptoms, and it may involve several steps before a final answer.
Screening Tests That Catch Early Signs
Most people should begin screening for colorectal cancer soon after turning 45. The U.S. Preventive Services Task Force recommends regular screening from age 45 to 75. Several options exist, and the best one depends on your preferences and risk level.
Stool-based tests are the least invasive starting point. The fecal immunochemical test (FIT) checks for hidden blood in your stool and is done once a year. It detects about 81% of colorectal cancers but is less reliable for catching precancerous growths, picking up only about 26% of advanced precancerous changes. A multi-target stool DNA test (like Cologuard) combines a blood detection test with markers shed by abnormal cells. It catches roughly 92% of colorectal cancers and is done every three years, though its specificity is slightly lower than FIT, meaning it produces more false positives.
Other screening options include flexible sigmoidoscopy every five years, CT colonography (a virtual colonoscopy) every five years, and a full colonoscopy every 10 years for people at average risk. None of these screening tests alone confirm cancer. A positive result on any non-colonoscopy screening test leads to a diagnostic colonoscopy.
Colonoscopy: The Central Diagnostic Tool
A colonoscopy is the definitive test for diagnosing colon cancer. During the procedure, a doctor threads a long, flexible tube with a tiny video camera through the rectum and into the entire length of the colon. The colon is gently inflated with air or carbon dioxide to give a clear view of the lining. If the doctor spots anything abnormal, polyps, masses, or irregular tissue, they can pass small instruments through the tube to remove polyps or snip tissue samples on the spot.
The procedure itself typically takes 30 to 60 minutes, and you’ll be sedated, so you won’t feel it. The tissue samples collected are sent to a pathology lab, where the actual diagnosis happens. A colonoscopy without a biopsy can only identify suspicious areas. It’s the lab analysis that determines whether cancer cells are present.
Preparing for the Procedure
The preparation is often described as the hardest part. About a week before, you’ll switch to a low-fiber diet and stop taking iron supplements. The day before the procedure, you move to clear liquids only: water, broth, plain gelatin, clear sports drinks, and tea or coffee without creamer. Nothing red or purple, since those colors can be mistaken for blood during the exam.
The evening before, you begin drinking a bowel-cleansing solution, typically about half a gallon consumed over several hours, eight ounces every 10 minutes. The second half is consumed starting six hours before your appointment. By the end, your stool should be clear yellow. You stop drinking all fluids two hours before the procedure. The goal is a completely clean colon so the doctor can see every inch of the lining.
Risks Are Low but Real
Colonoscopy is safe for the vast majority of people. The most significant risk, perforation of the colon wall, occurs in roughly 2 out of every 1,000 procedures. Bleeding at the site of a biopsy or polyp removal can also happen but is usually minor and self-limiting. These rates have improved over time as techniques have advanced.
What Happens in the Lab
Once a tissue sample reaches the pathology lab, a pathologist examines it under a microscope to determine whether the cells are cancerous and, if so, how aggressive they appear. This analysis, called a biopsy, is what officially confirms a colon cancer diagnosis. The pathologist looks at the cell type (most colon cancers are adenocarcinomas, meaning they start in the gland cells lining the colon) and grades how abnormal the cells look compared to healthy tissue.
Beyond the basic diagnosis, the lab runs molecular and genetic tests on the tumor that directly shape treatment decisions. These include testing for mutations in genes called KRAS, NRAS, and BRAF, which tell oncologists whether certain targeted therapies will work. The lab also checks for a feature called mismatch repair deficiency or microsatellite instability, which indicates whether the tumor’s DNA repair system is broken. Tumors with this feature often respond well to immunotherapy. If a protein called MLH1 is missing, additional testing for a chemical change called promoter methylation helps distinguish between a sporadic cancer and one linked to an inherited condition called Lynch syndrome.
HER2 testing may also be performed, particularly in cases where the cancer has spread. Taken together, these molecular results create a profile of the individual tumor that guides nearly every treatment decision that follows.
Blood Tests: Useful but Not Diagnostic
No blood test can diagnose colon cancer on its own. A test called CEA (carcinoembryonic antigen) is sometimes associated with colorectal cancer, but doctors do not use it for screening or diagnosis. CEA levels can be elevated by dozens of noncancerous conditions, including liver disease, inflammatory bowel disease, COPD, diabetes, smoking, and even hemorrhoids. You can have high CEA without having cancer, and you can have cancer with normal CEA.
Blood tests do play a supporting role. A complete blood count might reveal anemia, a low red blood cell count that could suggest a tumor is causing slow, hidden bleeding. Liver and kidney function tests help assess overall health and can hint at whether cancer may have spread to those organs. But these are clues, not confirmations.
Staging: Determining How Far It Has Spread
Once colon cancer is confirmed by biopsy, the next step is staging, which determines how deeply the tumor has grown into the colon wall and whether it has reached nearby lymph nodes or distant organs. Staging is critical because it determines whether surgery alone is sufficient or whether additional treatments like chemotherapy are needed.
CT scans of the abdomen, pelvis, and chest are the standard first-line imaging for staging. They provide a broad picture of the tumor’s size, whether lymph nodes appear enlarged, and whether there are signs of spread to the liver or lungs, the most common sites of colon cancer metastasis.
MRI offers more detail about the tumor itself, particularly how deeply it has invaded the colon wall. It’s strong at distinguishing between tumors confined to the inner layers and those that have broken through to the outer surface, with a sensitivity of about 81% for that distinction. PET/CT scans, which highlight areas of high metabolic activity, can help evaluate suspicious lymph nodes. PET/CT is quite good at ruling out lymph node involvement when results are negative (about 88% specificity), though both MRI and PET/CT miss a meaningful percentage of affected lymph nodes. Final, definitive staging often comes only after surgery, when the removed tissue and surrounding lymph nodes are examined in the lab.
Genetic Testing for Hereditary Risk
Some colon cancers are driven by inherited genetic conditions, the most common being Lynch syndrome. Genetic testing is typically recommended if your tumor shows abnormal mismatch repair results in the lab, if you were diagnosed at a young age, if you’ve had multiple cancers, or if several family members have had cancers linked to Lynch syndrome (including uterine, ovarian, and stomach cancers).
Identifying Lynch syndrome matters beyond your own diagnosis. It means close family members can be tested and, if positive, screened earlier and more frequently. Many cancer centers now routinely test all newly diagnosed colorectal tumors for mismatch repair deficiency as a first step, regardless of age or family history, since this information also influences treatment choices.